Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    savita thakur thakur
    savita thakur thakur
      • Home
      • savita thakur thakur

      Articles By : savita thakur thakur

      Novartis intensifies Entresto push with new analysis

      Novartis intensifies Entresto push with new analysis

      savita thakur thakur20 Sept 2016 11:09 AM IST
      Novartis intensified its bid to convince doctors to prescribe its heart failure drug Entresto, releasing an analysis that concluded the medicine...
      Biocon appoints Suresh Subramanian as Head of Branded Formulations India Business

      Biocon appoints Suresh Subramanian as Head of Branded Formulations India Business

      savita thakur thakur20 Sept 2016 11:08 AM IST
      Mumbai : Biocon Ltd, Asia's premier bio pharmaceuticals company, announced that Suresh Subramanian has been appointed as Head of the Company's Branded...
      FDA permits marketing of balloon device to treat persistent Eustachian tube dysfunction

      FDA permits marketing of balloon device to treat persistent Eustachian tube dysfunction

      savita thakur thakur20 Sept 2016 11:07 AM IST
      The U.S. Food and Drug Administration permitted marketing of a device that uses a small balloon to treat persistent Eustachian tube dysfunction (ETD),...
      GE brings off the shelf biotech drug factories to Ireland

      GE brings off the shelf biotech drug factories to Ireland

      savita thakur thakur20 Sept 2016 11:07 AM IST
      London : General Electric is digging deeper into biotechnology with plans to build four prefabricated drug factories in Ireland, bringing to Europe a...
      Valeant says discount program for heart drugs on track

      Valeant says discount program for heart drugs on track

      savita thakur thakur19 Sept 2016 1:56 PM IST
      Valeant Pharmaceuticals International Inc said its discount and rebates program for two high-priced heart drugs would cover over 90 percent U.S....
      EMA panel recommends nod for Pfizers breast cancer drug, Ibrance

      EMA panel recommends nod for Pfizers breast cancer drug, Ibrance

      savita thakur thakur19 Sept 2016 1:30 PM IST
      U.S. drugmaker Pfizer Inc's breast cancer drug, Ibrance, should be given marketing approval, an advisory committee at the European Medicines Agency...
      Star Health eyes Rs 2,800 cr gross written premium this fiscal

      Star Health eyes Rs 2,800 cr gross written premium this fiscal

      savita thakur thakur19 Sept 2016 1:28 PM IST
      Mumbai : The largest stand alone health insurance provider, Star Health and Allied Insurance, is eyeing gross written premium of Rs 2,800 crore by the...
      Indian company joins hands with Massachusetts General Hospital  for 3D post-processing services

      Indian company joins hands with Massachusetts General Hospital for 3D post-processing services

      savita thakur thakur19 Sept 2016 1:20 PM IST
      Bengaluru : City based tele diagnostic delivery company Tele radiology Solutions (TRS) announced a collaboration with Massachusetts General Hospital...
      Johnson n Johnson to buy Abbotts vision unit for 4.33 billion dollars

      Johnson n Johnson to buy Abbotts vision unit for 4.33 billion dollars

      savita thakur thakur18 Sept 2016 9:39 AM IST
      Johnson & Johnson said that it is paying more than $4.3 billion in cash to buy the eye health unit of Abbott Laboratories as it seeks to boost its...
      Dr Reddy Labs inks pact with Amgen to market three drugs in India

      Dr Reddy Labs inks pact with Amgen to market three drugs in India

      savita thakur thakur18 Sept 2016 9:34 AM IST
      Hyderabad : Dr Reddy's Laboratories (DRL) has expanded its strategic collaboration with US based independent biotechnology firm Amgen to market and...
      Natco to file over 10 ANDAs in US in next 2 fiscals

      Natco to file over 10 ANDAs in US in next 2 fiscals

      savita thakur thakur18 Sept 2016 9:34 AM IST
      New Delhi : Drug firm Natco Pharma is aiming to file over 10 Abbreviated New Drug Applications (ANDAs) in the US in the next two financial years to...
      Themis Medicare inks pact with Nevakar for injectable products

      Themis Medicare inks pact with Nevakar for injectable products

      savita thakur thakur18 Sept 2016 9:34 AM IST
      New Delhi : Drug firm Themis Medicare has signed an agreement with Nevakar LLC to further develop, manufacture and market latter's injectable products...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok